When was LABORATORIUM M. NUYTINCK founded?

LABORATORIUM M. NUYTINCK was founded on 01 Jul 1985, making it 41 years old.

Is LABORATORIUM M. NUYTINCK still active?

Yes, LABORATORIUM M. NUYTINCK is currently active.

What does LABORATORIUM M. NUYTINCK do?

LABORATORIUM M. NUYTINCK's registered main activity is Diagnostic imaging services and medical laboratory activities.

Where is LABORATORIUM M. NUYTINCK registered?

LABORATORIUM M. NUYTINCK's registered address is Noorwegenstraat 4, 9940 Evergem, Belgium.

How many employees does LABORATORIUM M. NUYTINCK have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2024), LABORATORIUM M. NUYTINCK reported 81.1 full-time equivalent employees.

What is LABORATORIUM M. NUYTINCK's annual turnover?

LABORATORIUM M. NUYTINCK's most recently filed annual turnover (fiscal year ending 31 Dec 2024) was €23,747,548.

Did LABORATORIUM M. NUYTINCK make a profit or a loss?

LABORATORIUM M. NUYTINCK's most recently filed annual accounts (fiscal year ending 31 Dec 2024) reported a loss of €369,408.

When did LABORATORIUM M. NUYTINCK last file annual accounts?

LABORATORIUM M. NUYTINCK's most recently filed annual accounts cover the fiscal year ending 31 Dec 2024.

Is LABORATORIUM M. NUYTINCK B Corp certified?

We have no B Corp certification on file for LABORATORIUM M. NUYTINCK.

Does LABORATORIUM M. NUYTINCK hold Fairtrade certification?

No, LABORATORIUM M. NUYTINCK does not currently hold Fairtrade certification.

LABORATORIUM M. NUYTINCK

BE 0427.563.924

Copied!

BV/SRL

Status

Active

Founded

01 Jul 1985

Size

Medium · 81.1 FTE

Age

41 yrs

Main activity

Diagnostic imaging services and medical laboratory activities

Activities

1 activity

Diagnostic imaging services and medical laboratory activities

Financials

Turnover2024

€23.7M-0.5%

Profit / Loss2024

−€369K-164.8%

Equity2024

€8.5M-48.1%

2024	2023	2022	2021
€23,747,548-0.5%	€23,871,341-6.8%	€25,622,611-20.4%	€32,197,698
-€369,408-164.8%	€570,033-65.6%	€1,658,534-60.9%	€4,247,385
€8,478,356-48.1%	€16,347,764+3.6%	€15,777,732+11.8%	€14,119,198
€3,063,603-3.5%	€3,174,213+10.4%	€2,875,154-26.7%	€3,921,825
€2,624,520+3%	€2,547,610-74.4%	€9,947,790+79.6%	€5,539,436
81.1+2.4%	79.2+1.4%	78.1+2.6%	76.1
€292,818-2.8%	€301,406-8.1%	€328,074-22.5%	€423,097

Frequently asked questions

01What is LABORATORIUM M. NUYTINCK's official registered name?

LABORATORIUM M. NUYTINCK.

02What is LABORATORIUM M. NUYTINCK's enterprise number (VAT number)?

BE 0427.563.924.

03What is LABORATORIUM M. NUYTINCK's legal form?

Besloten Vennootschap (BV) / Société à responsabilité limitée (SRL).

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

Financial statements

	2024	2023	2022	2021
Income statement
	€23,747,548-0.5%	€23,871,341-6.8%	€25,622,611-20.4%	€32,197,698
	81.1+2.4%	79.2+1.4%	78.1+2.6%	76.1
	€292,818-2.8%	€301,406-8.1%	€328,074-22.5%	€423,097
	€5,678,386+8.3%	€5,241,916+10.9%	€4,728,211+7.9%	€4,383,317
	-€578,508-206.1%	€545,466-74.1%	€2,107,368-62.3%	€5,592,495
	€503,903-51.4%	€1,036,529-60.1%	€2,599,790-58.7%	€6,293,931
	-€369,408-164.8%	€570,033-65.6%	€1,658,534-60.9%	€4,247,385
	€153,450+13.6%	€135,130-39.8%	€224,403-39.3%	€369,779
Profitability
	2.1%-51.1%	4.3%-57.2%	10.1%-48.1%	19.5%
	-1.6%-165.1%	2.4%-63.1%	6.5%-50.9%	13.2%
	-4.4%-225%	3.5%-66.8%	10.5%-65.1%	30.1%
	-3.2%-209.6%	2.9%-67.2%	8.9%-62.2%	23.5%
Solvency
	€11,541,959-40.9%	€19,521,977+4.7%	€18,652,886+3.4%	€18,041,023
	€3,476,529+53.4%	€2,267,125+162.3%	€864,314-25%	€1,151,980
	€9,2960%	€9,2960%	€9,2960%	€9,296
	€8,478,356-48.1%	€16,347,764+3.6%	€15,777,732+11.8%	€14,119,198
	73.5%-12.3%	83.7%-1%	84.6%+8.1%	78.3%
	€3,063,603-3.5%	€3,174,213+10.4%	€2,875,154-26.7%	€3,921,825
	0.36+86.1%	0.19+6.6%	0.18-34.4%	0.28
	-149.66-390.9%	51.45+66.4%	30.92-52.7%	65.41
Liquidity
	€2,624,520+3%	€2,547,610-74.4%	€9,947,790+79.6%	€5,539,436
	€574,913-6.8%	€617,174+1.1%	€610,408-39.6%	€1,010,354
	€3,761,842-27%	€5,150,535+18.2%	€4,357,961-34.1%	€6,614,118
	€2,066,377-0.4%	€2,074,999+19.9%	€1,730,211-31.9%	€2,541,379
	€3,054,665-2.4%	€3,130,464+11.6%	€2,806,276-26.5%	€3,818,508
	1.54-64.5%	4.32+124.7%	1.93-8.3%	2.10
	€4,269,962-67.4%	€13,101,176+3.9%	€12,607,338+28%	€9,853,034
Efficiency
	58 days-26.6%	79 days+26.9%	62 days-17.2%	75 days
	39 days-0.1%	39 days+25%	32 days-17.4%	38 days
	74 days+3.3%	72 days+37.8%	52 days-7.9%	56 days
	4.76-7.2%	5.13-3%	5.29	—
Profit appropriation
	€7,500,000	—	—	—
	€8,078,750-40.5%	€13,578,750+214.5%	€4,318,0880%	€4,318,088
	€288,827-89.1%	€2,658,235-76.6%	€11,364,366+17.1%	€9,705,833

Sources

NBB — Nationale Bank van België

	2024	2023	2022	2021
Income statement
	€23,747,548-0.5%	€23,871,341-6.8%	€25,622,611-20.4%	€32,197,698
	81.1+2.4%	79.2+1.4%	78.1+2.6%	76.1
	€292,818-2.8%	€301,406-8.1%	€328,074-22.5%	€423,097
	€5,678,386+8.3%	€5,241,916+10.9%	€4,728,211+7.9%	€4,383,317
	-€578,508-206.1%	€545,466-74.1%	€2,107,368-62.3%	€5,592,495
	€503,903-51.4%	€1,036,529-60.1%	€2,599,790-58.7%	€6,293,931
	-€369,408-164.8%	€570,033-65.6%	€1,658,534-60.9%	€4,247,385
	€153,450+13.6%	€135,130-39.8%	€224,403-39.3%	€369,779
Profitability
	2.1%-51.1%	4.3%-57.2%	10.1%-48.1%	19.5%
	-1.6%-165.1%	2.4%-63.1%	6.5%-50.9%	13.2%
	-4.4%-225%	3.5%-66.8%	10.5%-65.1%	30.1%
	-3.2%-209.6%	2.9%-67.2%	8.9%-62.2%	23.5%
Solvency
	€11,541,959-40.9%	€19,521,977+4.7%	€18,652,886+3.4%	€18,041,023
	€3,476,529+53.4%	€2,267,125+162.3%	€864,314-25%	€1,151,980
	€9,2960%	€9,2960%	€9,2960%	€9,296
	€8,478,356-48.1%	€16,347,764+3.6%	€15,777,732+11.8%	€14,119,198
	73.5%-12.3%	83.7%-1%	84.6%+8.1%	78.3%
	€3,063,603-3.5%	€3,174,213+10.4%	€2,875,154-26.7%	€3,921,825
	0.36+86.1%	0.19+6.6%	0.18-34.4%	0.28
	-149.66-390.9%	51.45+66.4%	30.92-52.7%	65.41
Liquidity
	€2,624,520+3%	€2,547,610-74.4%	€9,947,790+79.6%	€5,539,436
	€574,913-6.8%	€617,174+1.1%	€610,408-39.6%	€1,010,354
	€3,761,842-27%	€5,150,535+18.2%	€4,357,961-34.1%	€6,614,118
	€2,066,377-0.4%	€2,074,999+19.9%	€1,730,211-31.9%	€2,541,379
	€3,054,665-2.4%	€3,130,464+11.6%	€2,806,276-26.5%	€3,818,508
	1.54-64.5%	4.32+124.7%	1.93-8.3%	2.10
	€4,269,962-67.4%	€13,101,176+3.9%	€12,607,338+28%	€9,853,034
Efficiency
	58 days-26.6%	79 days+26.9%	62 days-17.2%	75 days
	39 days-0.1%	39 days+25%	32 days-17.4%	38 days
	74 days+3.3%	72 days+37.8%	52 days-7.9%	56 days
	4.76-7.2%	5.13-3%	5.29	—
Profit appropriation
	€7,500,000	—	—	—
	€8,078,750-40.5%	€13,578,750+214.5%	€4,318,0880%	€4,318,088
	€288,827-89.1%	€2,658,235-76.6%	€11,364,366+17.1%	€9,705,833

2024

2023

2022

2021

Income statement

€23,747,548-0.5%

€23,871,341-6.8%

€25,622,611-20.4%

€32,197,698

81.1+2.4%

79.2+1.4%

78.1+2.6%

76.1

€292,818-2.8%

€301,406-8.1%

€328,074-22.5%

€423,097

€5,678,386+8.3%

€5,241,916+10.9%

€4,728,211+7.9%

€4,383,317

-€578,508-206.1%

€545,466-74.1%

€2,107,368-62.3%

€5,592,495

€503,903-51.4%

€1,036,529-60.1%

€2,599,790-58.7%

€6,293,931

-€369,408-164.8%

€570,033-65.6%

€1,658,534-60.9%

€4,247,385

€153,450+13.6%

€135,130-39.8%

€224,403-39.3%

€369,779

Profitability

2.1%-51.1%

4.3%-57.2%

10.1%-48.1%

19.5%

-1.6%-165.1%

2.4%-63.1%

6.5%-50.9%

13.2%

-4.4%-225%

3.5%-66.8%

10.5%-65.1%

30.1%

-3.2%-209.6%

2.9%-67.2%

8.9%-62.2%

23.5%

Solvency

€11,541,959-40.9%

€19,521,977+4.7%

€18,652,886+3.4%

€18,041,023

€3,476,529+53.4%

€2,267,125+162.3%

€864,314-25%

€1,151,980

€9,2960%

€9,296

€8,478,356-48.1%

€16,347,764+3.6%

€15,777,732+11.8%

€14,119,198

73.5%-12.3%

83.7%-1%

84.6%+8.1%

78.3%

€3,063,603-3.5%

€3,174,213+10.4%

€2,875,154-26.7%

€3,921,825

0.36+86.1%

0.19+6.6%

0.18-34.4%

0.28

-149.66-390.9%

51.45+66.4%

30.92-52.7%

65.41

Liquidity

€2,624,520+3%

€2,547,610-74.4%

€9,947,790+79.6%

€5,539,436

€574,913-6.8%

€617,174+1.1%

€610,408-39.6%

€1,010,354

€3,761,842-27%

€5,150,535+18.2%

€4,357,961-34.1%

€6,614,118

€2,066,377-0.4%

€2,074,999+19.9%

€1,730,211-31.9%

€2,541,379

€3,054,665-2.4%

€3,130,464+11.6%

€2,806,276-26.5%

€3,818,508

1.54-64.5%

4.32+124.7%

1.93-8.3%

2.10

€4,269,962-67.4%

€13,101,176+3.9%

€12,607,338+28%

€9,853,034

Efficiency

58 days-26.6%

79 days+26.9%

62 days-17.2%

75 days

39 days-0.1%

39 days+25%

32 days-17.4%

38 days

74 days+3.3%

72 days+37.8%

52 days-7.9%

56 days

4.76-7.2%

5.13-3%

5.29

—

Profit appropriation

€7,500,000

—

€8,078,750-40.5%

€13,578,750+214.5%

€4,318,0880%

€4,318,088

€288,827-89.1%

€2,658,235-76.6%

€11,364,366+17.1%

€9,705,833

LABORATORIUM M. NUYTINCK

Activities

Financials

Frequently asked questions

All locations

Financial statements

Financial statements

All locations